Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
Sabela Bobillo, Pau Abrisqueta, Cecilia Carpio, Priyanka Raheja, Josep Castellví, Marta Crespo, Francesc Bosch
Haematologica December 2017 : haematol.2017.181636; doi:10.3324/haematol.2017.181636
Sabela Bobillo
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pau Abrisqueta
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Carpio
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priyanka Raheja
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josep Castellví
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Crespo
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesc Bosch
Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Sabela Bobillo,
  2. Pau Abrisqueta,
  3. Cecilia Carpio,
  4. Priyanka Raheja,
  5. Josep Castellví,
  6. Marta Crespo and
  7. Francesc Bosch*
  1. Department of Hematology and Vall d' Hebron Institute of Oncology, Barcelona, Spain
  1. ↵* Corresponding author; email: fbosch{at}vhebron.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

-

  • Received October 3, 2017.
  • Accepted December 7, 2017.
  • Copyright © 2017, Ferrata Storti Foundation
Next
Back to top

Keywords

Aggressive Non-Hodgkin's Lymphoma
Lymphoproliferative Disorders
CNS lymphoma

Vol 104 Issue 2

Haematologica: 104 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Citation Tools
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
Sabela Bobillo, Pau Abrisqueta, Cecilia Carpio, Priyanka Raheja, Josep Castellví, Marta Crespo, Francesc Bosch
Haematologica Dec 2017, haematol.2017.181636; DOI: 10.3324/haematol.2017.181636

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Sabela Bobillo, Pau Abrisqueta, Cecilia Carpio, Priyanka Raheja, Josep Castellví, Marta Crespo, Francesc Bosch
Haematologica Dec 2017, haematol.2017.181636; DOI: 10.3324/haematol.2017.181636
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

Case Report

  • Venetoclax penetrates in cerebrospinal fluid and may be effective in CLL with central nervous system involvement.
  • Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia
  • Recognition of hemophagocytic lymphohistiocytosis in sickle cell vasoocclusive crises is a potentially lifesaving diagnosis
Show more Case Report

Non-Hodgkin Lymphoma

  • Burkitt-like lymphoma with 11q aberration: A germinal center derived lymphoma genetically unrelated to Burkitt lymphoma
  • The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity than SAR3419 in CD19-positive lymphoma and leukemia models
  • miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells
Show more Non-Hodgkin Lymphoma

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online